Radar Open Radar

The drug Nimolanzim has been registered in the Russian Federation for the treatment of malignant tumors The Russian Ministry of Health has registered the drug Nimolanzim for the treatment of adults with several malignant neoplasms, including tumors of the esophagus, head and neck, as well as certain types of malignant brain tumors, the ministry's press service reported. "The Russian Ministry of Health has registered the original drug Nimolantsim, the non-proprietary international name nimotozumab.

Интерфакс · Source

The drug Nimolanzim has been registered in the Russian Federation for the treatment of malignant tumors The Russian Ministry of Health has registered the drug Nimolanzim for the treatment of adults with several malignant neoplasms, including tumors of the esophagus, head and neck, as well as certain types of malignant brain tumors, the ministry's press service reported. "The Russian Ministry of Health has registered the original drug Nimolantsim, the non-proprietary international name nimotozumab.